BiPar Sciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BiPar Sciences, Inc. - overview
Location
South San Francisco, CA, US
Primary Industry
Pharmaceuticals
About
BiPar is a clinical-stage drug development company pioneering novel tumor-selective therapies designed to address urgent unmet needs of cancer patients.
Current Investors
Canaan Partners, PolyTechnos Venture-Partners, Asset Management Ventures
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.biparsciences.com
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.